“Biologics are the future of medicine. Continued investment in research and development by innovator biotech companies is critical to finding cures for life-threatening conditions – and to answering President Obama’s call to cure cancer in our lifetime.” – Senate Committee on health, Education Labor and Pensions
BIOLOGICS: THE PHARMACEUTICAL FUTURE
January 28th-29th, 2010 • Boston, MA
Understanding trends, identifying new markets, and creating revenue building partnerships: Maximizing success and mastering the highly competitive and dynamic Biologics marketplace
A Two-Day Forum highlighting the most current case studies and sales strategies from top Pharmaceutical Institutions. Learn about:
• • • • • • • • • • •
Keeping ahead of trends in biopharmaceuticals manufacturing Implementing new sales methods to achieve cost reductions Strategic approaches to maximizing the opportunities and minimizing threats of biosimilars What investors are looking for in the biopharmaceutical sector Successful business models for the future Current Pharma industry’s changing environment creating new biologics opportunities Evolution of bio-outsourcing in the next 10 years Developing a clinical outsourcing strategy Big Pharma to Big Biopharma – what does that mean for current biologics sellers Establishing and safeguarding a profitable approach to follow-on biologics How does biosimilar competition really affect market value of biologics
WHO SHOULD ATTEND?
The conference is ideally suited for the senior level executives, directors or division chiefs of pharmaceutical/biologic sales organizations • Senior Level Administrators • Executive Directors • Scientific Managers • Project & Quality Assurance Managers • National Sales Managers • Director of Pharma Sales • VP/Director of Marketing/Planning/PR • VP/Director Business Developmen
Active Communications International Phone: 312 780 0700 Fax: 312 780 0600 www.acius.net
BIOLOGICS: THE PHARMACEUTICAL FUTURE
January 28th-29th, 2010 • Boston, MA
PRIORITY INVITATIONS WILL BE EXTENDED TO: Abbott Laboratories Adrien Arpel, Inc. Agouron Pharmaceuticals, Inc. Akzo Nobel Albright & Wilson Ltd Alfacell Corporation Allergan Amarello Biosciences, Inc Amgen USA Amylin Pharmaceuticals Inc. Aphton Corporation Aquila Biopharmaceuticals, Inc. Astellas Pharma AstraZeneca Barr Pharmaceuticals Baxter Hemoglobin Therapeutics Biomarin Pharmaceutical Inc Biopure Corporation Biotech Holding Ltd. Bristol-Myers Squibb Celox Laboratories, Inc. Chiron Corporation Csl Limited Cypress Bioscience, Inc. Cytoclonal Pharmaceuticals Daiichi Pharmaceutical Co. Desoto, Inc. Duska Therapeutics, Inc Eisai Co. Eli Lilly and Company Enzon Pharmaceuticals, Inc Exact Sciences Corporation Exten Industries, Inc. Forest Laboratories Fornix Biosciences Genemedix Plc
Active Communications International Phone: 312 780 0700
Genentech Genitope Corporation Genzyme Gibson Chemical Industries Limited GlaxoSmithKline Hoffmann-La Roche Hualan Biological Engineering, Inc Hydron Technologies, Inc. ID Biomedical Corporation IDEC Pharmaceuticals Corporation Immetech International, Inc Immulogic Pharmaceutical Corporation La Maur Inc. Merck & Co. Microbix Biosystems Inc Mitsubishi Pharma Northfield Laboratories, Inc. Novartis Novavax, Inc. Pfizer Pharmexa AS Procter & Gamble Regeneron Pharmaceuticals Inc. Restoragen, Incorporated Sanofi-Aventis Schering-Plough Sciclone Pharmaceuticals, Inc Solvay Sparta Pharmaceuticals, Inc. Takeda Pharmaceutical Co. Teva Pharmaceutical Industries Texas Biotechnology Corporation Watson Pharmaceuticals Wyeth USA
Fax: 312 780 0600
www.acius.net